Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Sanchez

Showing results (271-280 of 324) with videos related to

Pageof 33
Sort By:
The Journal of Urology|March 3, 2018
Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment ImagingMahyar Kashan, Mazyar Ghanaat, Andreas M Hötker, et al.
The Journal of Nutrition|May 21, 2026
Identification of circulating lipidomic biomarkers of malnutrition risk among oncology patients in the Total Cancer Care (TCC) Study: a cross-sectional analysisRachel Hoobler, J Alan Maschek, Bai Luo, et al.
Clinical Cardiology|June 14, 2024
Predictors of developing renal dysfunction following diagnosis of transthyretin cardiac amyloidosisMalcolm L McDonald, Yosef Manla, Alice Sonnino, et al.
The Lancet. Oncology|December 25, 2019
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort studyAlejandro Sanchez, Helena Furberg, Fengshen Kuo, et al.
Cancer Discovery|January 10, 2019
Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III TrialA Ari Hakimi, Martin H Voss, Fengshen Kuo, et al.
BJU International|August 17, 2023
Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified studyKyle A Blum, Andrew W Silagy, Andrea Knezevic, et al.
BMC Medical Genomics|April 17, 2015
The DNA methylation drift of the atherosclerotic aorta increases with lesion progressionMaría del Pilar Valencia-Morales, Silvio Zaina, Holger Heyn, et al.
Journal for Immunotherapy of Cancer|March 18, 2025
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)Gliceida M Galarza Fortuna, Daniel Grass, Benjamin L Maughan, et al.
Microbial Genomics|December 19, 2023
SARS-CoV-2 Omicron variants BA.4 and BA.5 dominated the fifth COVID-19 epidemiological wave in MexicoBlanca Itzelt Taboada, Selene Zárate, Rodrigo García-López, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2022
Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint BlockadeYasser Ged, Alejandro Sanchez, Sujata Patil, et al.
Pageof 33

Showing results (271-280 of 324) with videos related to

Sort By:
Pageof 33
The Journal of Urology|March 3, 2018
Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment ImagingMahyar Kashan, Mazyar Ghanaat, Andreas M Hötker, et al.
The Journal of Nutrition|May 21, 2026
Identification of circulating lipidomic biomarkers of malnutrition risk among oncology patients in the Total Cancer Care (TCC) Study: a cross-sectional analysisRachel Hoobler, J Alan Maschek, Bai Luo, et al.
Clinical Cardiology|June 14, 2024
Predictors of developing renal dysfunction following diagnosis of transthyretin cardiac amyloidosisMalcolm L McDonald, Yosef Manla, Alice Sonnino, et al.
The Lancet. Oncology|December 25, 2019
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort studyAlejandro Sanchez, Helena Furberg, Fengshen Kuo, et al.
Cancer Discovery|January 10, 2019
Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III TrialA Ari Hakimi, Martin H Voss, Fengshen Kuo, et al.
BJU International|August 17, 2023
Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified studyKyle A Blum, Andrew W Silagy, Andrea Knezevic, et al.
BMC Medical Genomics|April 17, 2015
The DNA methylation drift of the atherosclerotic aorta increases with lesion progressionMaría del Pilar Valencia-Morales, Silvio Zaina, Holger Heyn, et al.
Journal for Immunotherapy of Cancer|March 18, 2025
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)Gliceida M Galarza Fortuna, Daniel Grass, Benjamin L Maughan, et al.
Microbial Genomics|December 19, 2023
SARS-CoV-2 Omicron variants BA.4 and BA.5 dominated the fifth COVID-19 epidemiological wave in MexicoBlanca Itzelt Taboada, Selene Zárate, Rodrigo García-López, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2022
Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint BlockadeYasser Ged, Alejandro Sanchez, Sujata Patil, et al.
Pageof 33